Collaborations & Alliances
Related Searches:
Filter by:
676 - 690 of 1095 results
November 2, 2009
Amylin Pharmaceuticals and Takeda Pharmaceutical have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize compounds for the treatment of obesity and related indications.
Read More »
October 27, 2009
Scynexis, Inc. has received a payment from Merck for achieving a preclinical milestone in the companies’ oncology drug discovery and development collaboration.
Read More »
October 21, 2009
Xcellerex will help Novavax manufacture new H1N1 flu vaccine
Read More »
October 15, 2009
Evotec AG has extended its research collaboration with Ono Pharmaceutical Co., Ltd. and initiated a new discovery alliance.
Read More »
October 15, 2009
Azopharma and PharmaNet have formed a business development and co-promotion alliance
Read More »
October 14, 2009
Galapagos NV has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck to incorporate the development of new therapies for atherosclerosis
Read More »
October 9, 2009
Hospira has signed a business cooperation agreement with South Korea-based Celltrion for future distribution of biogeneric products in the U.S., Europe, Australia, New Zealand and Canada.
Read More »
October 2, 2009
Xcellerex and Itero Biopharmaceuticals have entered into a strategic collaboration for the production of Itero’s lead product, an undisclosed therapeutic protein.
Read More »
October 1, 2009
Merrimack Pharmaceuticals, Inc. and Sanofi-Aventis signed an exclusive worldwide licensing agreement for the development and commercialization of MM-121, a fully human monoclonal antibody designed to block signaling of the ErbB3 receptor.
Read More »
September 23, 2009
Opexa achieved its first milestone in its stem cell pact with Novartis.
Read More »
September 23, 2009
Azopharma will perform research services to further develop ImmuneRegen's lead drug candidate Homspera
Read More »
September 22, 2009
Avid Bioservices, Inc. and Boehringer Ingelheim have entered into a global strategic production alliance agreement, under which Avid will become an approved member of BI's global Production Alliance Network (PAN) Biologics.
Read More »
September 21, 2009
Icagen, Inc. and Pfizer have extended their worldwide collaboration and licensing agreement aimed at discovering, developing and commercializing compounds as new potential treatments for pain and related disorders.
Read More »
September 18, 2009
Wyeth and Ambrx, Inc. have formed a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets.
Read More »
September 18, 2009
Cambridge Regulatory Services (CambReg) has formed a strategic alliance with SIRO Clinpharm, a global Indian-based CRO, to provide services to pharma companies in both Asia and Europe.
Read More »
676 - 690 of 1095 results
